CLASS II ONGOING Device recall · Reported 15 Apr 2020 · FDA Enforcement Report

McKesson Cardiology ECG Management recalled by Change Healthcare Canada

Change Healthcare Canada is recalling McKesson Cardiology ECG Management, Change Healthcare Cardiology ECG Management, distributed nationwide in the US. The recall was initiated on 10 Feb 2020 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesMcKesson Cardiology Software Versions: 13.2.1 HF1, 13.2.1 HF2, 14.0, 14.0 HF1, 14.0 HF2; Change Healthcare Software Versions: 14.1.1, 14.2
Quantity recalled51 units

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-1682-2020
FDA event ID
85068
Recalling firm
Change Healthcare Canada, Richmond, British Co
Classification
Class II
Status
Ongoing
Recall initiated
10 Feb 2020
FDA classified
8 Apr 2020
Reported
15 Apr 2020
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Labeling Errors
Device type
Patient Monitors

Timeline

10 Feb 2020Recall initiated by company
8 Apr 2020Classified by FDA+58 days
15 Apr 2020Published in enforcement report+7 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Inaccurate estimation of the heart rate may occur in instances where the user is estimating heart rate counting grid squares using the Sequential ECG format

Product as listed by the FDA

McKesson Cardiology ECG Management, Change Healthcare Cardiology ECG Management

Where it was distributed

Distribution US nationwide, Canada and the United Kingdom

Nationwide

Questions about this recall

Why was it recalled?

Inaccurate estimation of the heart rate may occur in instances where the user is estimating heart rate counting grid squares using the Sequential ECG format

Which lots are affected?

McKesson Cardiology Software Versions: 13.2.1 HF1, 13.2.1 HF2, 14.0, 14.0 HF1, 14.0 HF2; Change Healthcare Software Versions: 14.1.1, 14.2

Where was it sold?

Distribution US nationwide, Canada and the United Kingdom

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Change Healthcare Canada

All 12

Other Patient Monitors recalls

All 1,022